Gilead Sciences

Recent news

• Rating change
  Barclays Maintains Gilead Sciences(GILD.US) With Hold Rating, Maintains Target Price $145
  Market Newswire · 2026/8/14
• Rating change
  A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $160 to $174
  Market Newswire · 2026/8/6
• Rating change
  Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Cuts Target Price to $165
  Market Newswire · 2026/7/27
• Rating change
  Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165
  Market Newswire · 2026/8/21
• Rating change
  Maxim Group Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165
  Market Newswire · 2026/8/8
• Rating change
  Truist Financial Maintains Gilead Sciences(GILD.US) With Buy Rating
  Market Newswire · 2026/8/28
• Rating change
  J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $160
  Market Newswire · 2026/8/7
• Rating change
  BMO Capital Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $174
  Market Newswire · 2026/8/28
• UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175
  Market Newswire · 2026/10/9
• Rating change
  Citi Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165
  Market Newswire · 2026/7/16
• Rating change
  J.P. Morgan Remains a Buy on Gilead Sciences (GILD)
  TipRanks · 2026/10/7
• Rating change
  Cantor Fitzgerald Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $155
  Market Newswire · 2026/7/30
• Rating change
  Mizuho Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $170
  Market Newswire · 2026/8/31
• J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $170
  Market Newswire · 2026/10/7
• Truist Financial Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $158
  Market Newswire · 2026/10/7
• Rating change
  Barclays Maintains Gilead Sciences(GILD.US) With Hold Rating, Cuts Target Price to $145
  Market Newswire · 2026/7/29
• Rating change
  A Quick Look at Today's Ratings for Gilead Sciences(GILD.US), With a Forecast Between $150 to $177
  Market Newswire · 2026/8/5
• Rating change
  Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $160
  Market Newswire · 2026/9/8
• Scotiabank Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $177
  Market Newswire · 2026/10/8
• Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Cuts Target Price to $163
  Market Newswire · 2026/10/7
• Rating change
  BofA Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $162
  Market Newswire · 2026/7/13
• Rating change
  Wells Fargo Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $165
  Market Newswire · 2026/7/10
• UBS Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $175
  Market Newswire · 2026/9/25
• Rating change
  J.P. Morgan Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $160
  Market Newswire · 2026/7/9
• Rating change
  Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Cuts Target Price to $166
  Market Newswire · 2026/7/8

Headlines are aggregated automatically and are not independently verified or edited by our team.